These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Ectopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cells. Ramesh R; Ito I; Gopalan B; Saito Y; Mhashilkar AM; Chada S Mol Ther; 2004 Apr; 9(4):510-8. PubMed ID: 15093181 [TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells. Sieger KA; Mhashilkar AM; Stewart A; Sutton RB; Strube RW; Chen SY; Pataer A; Swisher SG; Grimm EA; Ramesh R; Chada S Mol Ther; 2004 Mar; 9(3):355-67. PubMed ID: 15006602 [TBL] [Abstract][Full Text] [Related]
9. Enhanced therapeutic efficacy of adenovirus-mediated interleukin-24 gene therapy combined with ionizing radiotherapy for nasopharyngeal carcinoma. Liu J; Zhang Y; Sun P; Xie Y; Xiang J; Yang J Oncol Rep; 2013 Sep; 30(3):1165-74. PubMed ID: 23783436 [TBL] [Abstract][Full Text] [Related]
10. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy. Ling C; Xie Y; Zhao D; Zhu Y; Xiang J; Yang J Cancer Gene Ther; 2012 Oct; 19(10):697-706. PubMed ID: 22863759 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated ING4/IL-24 double tumor suppressor gene co-transfer enhances antitumor activity in human breast cancer cells. Zhao Y; Li Z; Sheng W; Miao J; Yang J Oncol Rep; 2012 Oct; 28(4):1315-24. PubMed ID: 22842937 [TBL] [Abstract][Full Text] [Related]
12. Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy. Xu Y; Zhang F; Qin L; Miao J; Sheng W; Xie Y; Xu X; Yang J; Qian H Melanoma Res; 2014 Feb; 24(1):20-31. PubMed ID: 24300090 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of nuclear factor-kappaB augments antitumor activity of adenovirus-mediated melanoma differentiation-associated gene-7 against lung cancer cells via mitogen-activated protein kinase kinase kinase 1 activation. Oida Y; Gopalan B; Miyahara R; Branch CD; Chiao P; Chada S; Ramesh R Mol Cancer Ther; 2007 Apr; 6(4):1440-9. PubMed ID: 17431123 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer. Cao C; Albert JM; Geng L; Ivy PS; Sandler A; Johnson DH; Lu B Cancer Res; 2006 Dec; 66(23):11409-15. PubMed ID: 17145887 [TBL] [Abstract][Full Text] [Related]
16. Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells. McKenzie T; Liu Y; Fanale M; Swisher SG; Chada S; Hunt KK Surgery; 2004 Aug; 136(2):437-42. PubMed ID: 15300212 [TBL] [Abstract][Full Text] [Related]
17. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo. Saeki T; Mhashilkar A; Swanson X; Zou-Yang XH; Sieger K; Kawabe S; Branch CD; Zumstein L; Meyn RE; Roth JA; Chada S; Ramesh R Oncogene; 2002 Jul; 21(29):4558-66. PubMed ID: 12085234 [TBL] [Abstract][Full Text] [Related]
19. mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family members. Chada S; Mhashilkar AM; Liu Y; Nishikawa T; Bocangel D; Zheng M; Vorburger SA; Pataer A; Swisher SG; Ramesh R; Kawase K; Meyn RE; Hunt KK Cancer Gene Ther; 2006 May; 13(5):490-502. PubMed ID: 16282987 [TBL] [Abstract][Full Text] [Related]